null

SMILES: CS(=O)(=O)c1ccccc1-c1ccc(N2CCCC(NC(=O)Nc3ccc(F)cc3)C2=O)c(F)c1

InChI Key: InChIKey=FTRIDQKZSFIDSE-UHFFFAOYSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 454181   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM454181 (US10717708, Example 28 | US11186544, Example 28) Show SMILES CS(=O)(=O)c1ccccc1-c1ccc(N2CCCC(NC(=O)Nc3ccc(F)cc3)C2=O)c(F)c1 Show InChI InChI=1S/C25H23F2N3O4S/c1-35(33,34)23-7-3-2-5-19(23)16-8-13-22(20(27)15-16)30-14-4-6-21(24(30)31)29-25(32)28-18-11-9-17(26)10-12-18/h2-3,5,7-13,15,21H,4,6,14H2,1H3,(H2,28,29,32)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	560	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US10717708 (2020)
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM454181 (US10717708, Example 28 | US11186544, Example 28) Show SMILES CS(=O)(=O)c1ccccc1-c1ccc(N2CCCC(NC(=O)Nc3ccc(F)cc3)C2=O)c(F)c1 Show InChI InChI=1S/C25H23F2N3O4S/c1-35(33,34)23-7-3-2-5-19(23)16-8-13-22(20(27)15-16)30-14-4-6-21(24(30)31)29-25(32)28-18-11-9-17(26)10-12-18/h2-3,5,7-13,15,21H,4,6,14H2,1H3,(H2,28,29,32)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	n/a	n/a	1.20E+3	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM454181 (US10717708, Example 28 | US11186544, Example 28) Show SMILES CS(=O)(=O)c1ccccc1-c1ccc(N2CCCC(NC(=O)Nc3ccc(F)cc3)C2=O)c(F)c1 Show InChI InChI=1S/C25H23F2N3O4S/c1-35(33,34)23-7-3-2-5-19(23)16-8-13-22(20(27)15-16)30-14-4-6-21(24(30)31)29-25(32)28-18-11-9-17(26)10-12-18/h2-3,5,7-13,15,21H,4,6,14H2,1H3,(H2,28,29,32)	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	n/a	n/a	560	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM454181 (US10717708, Example 28 | US11186544, Example 28) Show SMILES CS(=O)(=O)c1ccccc1-c1ccc(N2CCCC(NC(=O)Nc3ccc(F)cc3)C2=O)c(F)c1 Show InChI InChI=1S/C25H23F2N3O4S/c1-35(33,34)23-7-3-2-5-19(23)16-8-13-22(20(27)15-16)30-14-4-6-21(24(30)31)29-25(32)28-18-11-9-17(26)10-12-18/h2-3,5,7-13,15,21H,4,6,14H2,1H3,(H2,28,29,32)	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	1.20E+3	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US10717708 (2020)
					More data for this Ligand-Target Pair